To bridge critical research gaps, the International Mismatch Repair Consortium (IMRC) was formed in 2010 and comprises the major research and clinical groups in the world researching and treating Lynch syndrome (cancer predisposition caused by inherited mutations in mismatch repair genes: MLH1, MSH2, MSH6, PMS2 and EPCAM). The establishment of the IMRC was facilitated by the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) and by the Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA). Currently the IMRC includes approximately 231 members from 138 centres/clinics in 29 countries throughout Africa, Asia, Australasia, Europe, North and South America, all of whom provide clinical care and/or conduct research on Lynch syndrome families.

IMRC membership is open to anyone involved in research related to Lynch syndrome and/or the treatment of Lynch syndrome families. Current list of IMRC members. If you are interested in becoming a member of IMRC, please contact the coordinator, Allyson Templeton, This email address is being protected from spambots. You need JavaScript enabled to view it..

Each IMRC member can decide whether or not they would like to contribute to the consortium by:

1. Contributing data or analysis expertise to existing projects (email the project contact person), or
2. Proposing a new project (email IMRC coordinator, Allyson Templeton, This email address is being protected from spambots. You need JavaScript enabled to view it.)

Main contacts: